Potent cross-reactive antibodies following Omicron breakthrough in vaccinees. (2022)

First Author: Nutalai R
Attributed to:  Structural Studies on Viruses, Viral Proteins and Cell Interactions funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.cell.2022.05.014

PubMed Identifier: 35662412

Publication URI: http://europepmc.org/abstract/MED/35662412

Type: Journal Article/Review

Volume: 185

Parent Publication: Cell

Issue: 12

ISSN: 0092-8674